{"id":"inactive-substance","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL265889","moleculeType":"Protein","molecularWeight":"1347.66"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Inactive substances are used in clinical trials as control comparators to establish the efficacy and safety of active investigational drugs. They contain no active pharmaceutical ingredient and produce no intended therapeutic effect, allowing researchers to isolate the true effects of the test drug from placebo response.","oneSentence":"An inactive substance serves as a control or placebo with no pharmacological activity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:15:48.580Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07494305","phase":"PHASE2","title":"Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.","status":"RECRUITING","sponsor":"LB Pharmaceuticals Inc.","startDate":"2026-01-23","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT07489547","phase":"PHASE2, PHASE3","title":"Medication Withdrawal in Stable HF With Improved LVEF","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2025-03-01","conditions":"Heart Failure","enrollment":90},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT06269627","phase":"PHASE4","title":"Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2025-05-07","conditions":"Alcohol Use Disorder","enrollment":48},{"nctId":"NCT06450210","phase":"PHASE1","title":"Safety for Home Administration of Microdose Psilocybin Use","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-12-06","conditions":"Psychedelic Experiences","enrollment":20},{"nctId":"NCT06772753","phase":"PHASE1","title":"Investigation of Psychedelic Effects in Psychoactive Substances","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-05","conditions":"Psychedelic Effects in Healthy Volunteers","enrollment":50},{"nctId":"NCT07245979","phase":"NA","title":"Supplementation With Sirtuin Activators in Women With Increased Body Weight","status":"RECRUITING","sponsor":"Poznan University of Life Sciences","startDate":"2025-10-08","conditions":"Obesity & Overweight","enrollment":120},{"nctId":"NCT06084429","phase":"NA","title":"Developing School Health Champions to Increase Health Literacy Both in School Adolescents and Community People Through Providing Health Education by the School Nurses in Bangladesh: Community-based Pre- and Post-experimental Design","status":"COMPLETED","sponsor":"Hiroshima University","startDate":"2024-02-24","conditions":"Health Literacy","enrollment":138},{"nctId":"NCT05975580","phase":"PHASE4","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-08-29","conditions":"Obesity","enrollment":120},{"nctId":"NCT07408518","phase":"NA","title":"Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes","status":"RECRUITING","sponsor":"Synbiotic Health","startDate":"2026-01-20","conditions":"Digestive Disease, Gut Health","enrollment":92},{"nctId":"NCT07396857","phase":"NA","title":"The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-11-01","conditions":"Cardiovascular","enrollment":40},{"nctId":"NCT05671562","phase":"NA","title":"The Effect of Lycopene on Sperm Quality in Men Attending Fertility Clinic","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2023-05-03","conditions":"Total Motile Sperm Count","enrollment":34},{"nctId":"NCT05051644","phase":"PHASE1","title":"An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2022-04-01","conditions":"Opioid Use Disorder, Chronic Pain","enrollment":60},{"nctId":"NCT03652740","phase":"PHASE1","title":"Effects of Commonly Used Medications on Mood and Choice","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-10-02","conditions":"Healthy","enrollment":25},{"nctId":"NCT06546670","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-08-15","conditions":"Sickle Cell Disease","enrollment":161},{"nctId":"NCT00203684","phase":"PHASE1","title":"Mentored Patient-Oriented Research Career Development Award","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"","conditions":"Asthma, Distal Lung Inflammation","enrollment":57},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT07336797","phase":"PHASE2","title":"Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy","status":"RECRUITING","sponsor":"Abdelrahman Mahmoud","startDate":"2025-09-01","conditions":"Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)","enrollment":66},{"nctId":"NCT05080946","phase":"EARLY_PHASE1","title":"Using Aspirin to Improve Immunological Features of Ovarian Tumors","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2021-11-02","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","enrollment":100},{"nctId":"NCT07322679","phase":"NA","title":"Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","startDate":"2025-12-15","conditions":"Health Adult Subjects","enrollment":120},{"nctId":"NCT05422534","phase":"PHASE3","title":"CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-06-01","conditions":"End Stage Renal Disease","enrollment":156},{"nctId":"NCT04920864","phase":"NA","title":"rTMS, Stress and Opioid Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wayne State University","startDate":"2022-04-01","conditions":"Opioid Use Disorder","enrollment":32},{"nctId":"NCT07263139","phase":"PHASE2","title":"Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)","status":"RECRUITING","sponsor":"Agiana Pharmaceuticals","startDate":"2026-01-02","conditions":"Catecholaminergic Polymorphic Ventricular Tachycardia","enrollment":10},{"nctId":"NCT05785819","phase":"PHASE2","title":"A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia","status":"TERMINATED","sponsor":"Veralox Therapeutics","startDate":"2023-09-26","conditions":"Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia","enrollment":24},{"nctId":"NCT06344377","phase":"NA","title":"Betaine Supplementation and Lipid Metabolism in Overweight and Obese Pre-menopausal Women","status":"COMPLETED","sponsor":"Poznan University of Life Sciences","startDate":"2024-09-01","conditions":"Overweight and Obesity","enrollment":54},{"nctId":"NCT06047171","phase":"PHASE2","title":"Rescue of Nephrons With ALE.F02 (RENAL-F02)","status":"RECRUITING","sponsor":"Alentis Therapeutics AG","startDate":"2023-09-07","conditions":"Glomerulonephritis Rapidly Progressive","enrollment":80},{"nctId":"NCT06042855","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2023-09-05","conditions":"Covid19","enrollment":3214},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT06274528","phase":"PHASE2","title":"DORA and LP in Alzheimer's Disease Biomarkers","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-03-11","conditions":"Alzheimer Disease","enrollment":201},{"nctId":"NCT05908526","phase":"PHASE2","title":"Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2023-10-09","conditions":"Insomnia","enrollment":40},{"nctId":"NCT07210684","phase":"NA","title":"Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes","status":"RECRUITING","sponsor":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","startDate":"2025-08-06","conditions":"Prediabetes","enrollment":54},{"nctId":"NCT06436183","phase":"PHASE2","title":"A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Apollo Therapeutics Ltd","startDate":"2024-05-01","conditions":"Atopic Dermatitis, Atopic, Dermatitis","enrollment":62},{"nctId":"NCT05832567","phase":"NA","title":"Mechanisms of Open and Hidden Placebo in Stroke Recovery","status":"RECRUITING","sponsor":"Spaulding Rehabilitation Hospital","startDate":"2023-09-11","conditions":"Stroke, Hemiparesis","enrollment":56},{"nctId":"NCT06984484","phase":"NA","title":"Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease","status":"RECRUITING","sponsor":"Devintec Sagl","startDate":"2025-07-02","conditions":"Gastroesophageal Reflux Disease (GERD)","enrollment":208},{"nctId":"NCT07139964","phase":"NA","title":"High-Dose Vitamin D3 for Diabetic Foot Ulcer Healing: Randomized Controlled Trial","status":"COMPLETED","sponsor":"Universitas Sriwijaya","startDate":"2024-07-01","conditions":"Diabetic Foot Ulcer, Vitamin D Deficiency, Wound Healing Disorder","enrollment":24},{"nctId":"NCT06155331","phase":"PHASE2","title":"Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-12-01","conditions":"Breast Cancer Stage 2 and 3","enrollment":44},{"nctId":"NCT06573229","phase":"NA","title":"LIver FRAilty Management IN Cirrhosis (LIFRAMIN)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-08-02","conditions":"Sarcopenia, Cirrhosis, Liver, Malnutrition; Protein","enrollment":30},{"nctId":"NCT06891625","phase":"NA","title":"Movement Performance in Persons With Chronic Back Pain","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-09-01","conditions":"Chronic Low-back Pain, Back Disorder","enrollment":40},{"nctId":"NCT06997653","phase":"PHASE2","title":"Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women","status":"WITHDRAWN","sponsor":"Health Institutes of Turkey","startDate":"2024-01-01","conditions":"COVID-19, SARS CoV 2 Infection","enrollment":""},{"nctId":"NCT05414240","phase":"PHASE2","title":"Ibudilast for Treating Alcohol Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2023-01-14","conditions":"Alcohol Use Disorder (AUD), Alcoholism","enrollment":50},{"nctId":"NCT06960759","phase":"PHASE2","title":"Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough","status":"NOT_YET_RECRUITING","sponsor":"University of Montana","startDate":"2025-08-01","conditions":"Chronic Cough (CC), Refractory Chronic Cough, Unexplained Chronic Cough","enrollment":150},{"nctId":"NCT05548452","phase":"PHASE1, PHASE2","title":"Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2022-11-21","conditions":"Liver Disease; Alcohol-Related, Cirrhosis, Alcohol Use Disorder","enrollment":80},{"nctId":"NCT04377126","phase":"PHASE2","title":"Unacylated Ghrelin to Improve Functioning in PAD","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2020-07-08","conditions":"Peripheral Artery Disease","enrollment":25},{"nctId":"NCT05867849","phase":"PHASE3","title":"Cannabidiol for Bipolar Depression (CBD-BD)","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2023-10-15","conditions":"Bipolar Disorder","enrollment":360},{"nctId":"NCT05831241","phase":"NA","title":"Effects of Ashwagandha Extract (Capsule KSM-66 300 mg) on Sexual Health in Healthy Women","status":"COMPLETED","sponsor":"SF Research Institute, Inc.","startDate":"2023-07-12","conditions":"Sexual Health","enrollment":45},{"nctId":"NCT06869486","phase":"","title":"Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors","status":"RECRUITING","sponsor":"Universidad Autonoma de Baja California","startDate":"2024-10-01","conditions":"Insomnia, Cardiorespiratory Fitness, Metabolic Disease","enrollment":300},{"nctId":"NCT05605548","phase":"EARLY_PHASE1","title":"Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2023-02-16","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":4},{"nctId":"NCT06840184","phase":"NA","title":"Culturally Adapted Cognitive Behavioral Therapy Based Self Help Intervention for Mental Health of Caregivers of Individuals With Substance Use: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Fatima Jinnah Women University","startDate":"2024-08-20","conditions":"Psychological Stress, Quality of Life (QOL), Mental Health","enrollment":104},{"nctId":"NCT02731612","phase":"PHASE3","title":"Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients","status":"COMPLETED","sponsor":"Lakshmi N Yatham","startDate":"2017-05-08","conditions":"Bipolar Disorder","enrollment":100},{"nctId":"NCT06824571","phase":"NA","title":"Effects of Taurine Supplementation on Repetitive Sprint Performance and Exhaustion Time in College Students Under High-Temperature and High-Humidity Conditions","status":"COMPLETED","sponsor":"Xiaodong Cheng","startDate":"2024-12-01","conditions":"Exercise Performance in Extreme Environments","enrollment":16},{"nctId":"NCT06735079","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)","status":"WITHDRAWN","sponsor":"MGGM LLC","startDate":"2024-12-27","conditions":"Major Depressive Disorder (MDD)","enrollment":""},{"nctId":"NCT02476864","phase":"PHASE1","title":"Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults","status":"COMPLETED","sponsor":"Actelion","startDate":"2015-08","conditions":"Healthy Subjects","enrollment":12},{"nctId":"NCT05894577","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2023-01-27","conditions":"Covid19","enrollment":1453},{"nctId":"NCT03232138","phase":"PHASE2","title":"Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers","status":"COMPLETED","sponsor":"Jian-Min Yuan, MD","startDate":"2018-01-25","conditions":"Lung Cancer","enrollment":43},{"nctId":"NCT06727526","phase":"NA","title":"Acupressure's Impact on Pain and Physiological Parameters in Infants Undergoing Cardiac Catheterization","status":"NOT_YET_RECRUITING","sponsor":"Baskent University","startDate":"2024-12-30","conditions":"Cardiac Catheterization","enrollment":35},{"nctId":"NCT02506192","phase":"PHASE2","title":"Gulf War Illness Inflammation Reduction Trial","status":"COMPLETED","sponsor":"Minneapolis Veterans Affairs Medical Center","startDate":"2015-07","conditions":"Chronic Inflammation, Chronic Pain, Fatigue","enrollment":83},{"nctId":"NCT04710901","phase":"NA","title":"UTECH: Machine Learning for HIV Prevention Among Substance Using GBMSM","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-11-24","conditions":"Sexually Transmitted Diseases, HIV Infections, Implementation Science","enrollment":388},{"nctId":"NCT05894564","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2022-08-25","conditions":"Covid19","enrollment":1208},{"nctId":"NCT04771299","phase":"PHASE3","title":"Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients","status":"TERMINATED","sponsor":"Lakshmi N Yatham","startDate":"2021-07-07","conditions":"Bipolar I Disorder, Cognitive Impairment","enrollment":1},{"nctId":"NCT03277586","phase":"PHASE3","title":"Effects of Probiotics on Symptoms of Depression","status":"TERMINATED","sponsor":"Dr. Roumen Milev","startDate":"2018-05-29","conditions":"Depression, Anxiety","enrollment":28},{"nctId":"NCT06506643","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms","status":"RECRUITING","sponsor":"Vector Vitale LLC","startDate":"2024-05-15","conditions":"CLL, Solid Tumor, Adult","enrollment":36},{"nctId":"NCT02451748","phase":"PHASE4","title":"IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2015-08","conditions":"Rheumatoid Arthritis","enrollment":32},{"nctId":"NCT02965027","phase":"PHASE4","title":"Prazosin for Post-Concussive Headaches","status":"COMPLETED","sponsor":"Seattle Institute for Biomedical and Clinical Research","startDate":"2016-11-29","conditions":"Post-Traumatic Headache","enrollment":89},{"nctId":"NCT04782856","phase":"PHASE2","title":"Energy Metabolism in Thyroidectomized Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-10-28","conditions":"Thyroid Goiter, Hypothyroidism, Thyroid Cancer","enrollment":13},{"nctId":"NCT06384833","phase":"PHASE4","title":"Combination of Vitamin C and N-Acetylcysteine to Improve Functional Outcome After Rotator Cuff Repair","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2024-05-01","conditions":"Rotator Cuff Tears","enrollment":110},{"nctId":"NCT01751802","phase":"PHASE3","title":"Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease","status":"TERMINATED","sponsor":"Emalex Biosciences Inc.","startDate":"2012-12","conditions":"Lesch-Nyhan Disease, Self-injurious Behavior","enrollment":9},{"nctId":"NCT04985292","phase":"NA","title":"Does Probiotic Supplementation Prevent Kidney Injury During Strenuous Physical Exercise?","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2021-09-01","conditions":"Heat Stress, Kidney Injury","enrollment":43},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT05087914","phase":"PHASE2","title":"Novel Non-opioid Post-surgical Pain Treatment in Females","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2021-11-01","conditions":"Acute Pain, Bunionectomy, Toe Fusion","enrollment":""},{"nctId":"NCT03980561","phase":"PHASE2","title":"UH3 Varenicline for Cannabis Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-01-31","conditions":"Cannabis Use Disorder","enrollment":174},{"nctId":"NCT02414399","phase":"PHASE4","title":"Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children","status":"UNKNOWN","sponsor":"University of Washington","startDate":"2016-06-28","conditions":"Pneumonia, Diarrhea, Malaria","enrollment":1400},{"nctId":"NCT05894538","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2022-02-16","conditions":"Covid19","enrollment":1459},{"nctId":"NCT05909800","phase":"PHASE2","title":"Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2022-09-29","conditions":"Diabetes Mellitus, Type 1","enrollment":102},{"nctId":"NCT06088940","phase":"NA","title":"The Chemo-Gut Probiotic Trial for Cancer Survivors","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2023-11-10","conditions":"Cancer, Psychosocial Problem, Gastrointestinal Dysfunction","enrollment":66},{"nctId":"NCT06085378","phase":"NA","title":"Efficacy and Safety of Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke Combined With Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-01-01","conditions":"Acute Ischemic Stroke, Type 2 Diabetes","enrollment":630},{"nctId":"NCT02824627","phase":"PHASE2","title":"Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2017-01-27","conditions":"Mood Disorder, Disruptive Behavior Disorders","enrollment":58},{"nctId":"NCT02248701","phase":"PHASE2","title":"Testosterone Plus Finasteride Treatment After Spinal Cord Injury","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2017-04-27","conditions":"Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System","enrollment":33},{"nctId":"NCT05890586","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":1331},{"nctId":"NCT00536172","phase":"PHASE4","title":"Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2007-12-01","conditions":"Depression","enrollment":160},{"nctId":"NCT03712098","phase":"PHASE2","title":"Daily Liraglutide for Nicotine Dependence","status":"COMPLETED","sponsor":"Rebecca Ashare","startDate":"2018-11-29","conditions":"Smoking Cessation, Weight, Body","enrollment":40},{"nctId":"NCT04443608","phase":"PHASE4","title":"Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management","status":"TERMINATED","sponsor":"Comprehensive Research Associates","startDate":"2020-10-08","conditions":"Hyperkalemia","enrollment":115},{"nctId":"NCT03919799","phase":"PHASE2","title":"KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis","status":"TERMINATED","sponsor":"Kadmon, a Sanofi Company","startDate":"2019-06-26","conditions":"System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis","enrollment":36},{"nctId":"NCT02734485","phase":"NA","title":"Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy","status":"COMPLETED","sponsor":"IRCCS San Raffaele Roma","startDate":"2013-10","conditions":"Progressive Supranuclear Palsy, Parkinson's Disease","enrollment":20},{"nctId":"NCT05736874","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-08-06","conditions":"Covid19","enrollment":1407},{"nctId":"NCT05736861","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":1800},{"nctId":"NCT02410902","phase":"PHASE3","title":"A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)","status":"COMPLETED","sponsor":"Curemark","startDate":"2015-05-13","conditions":"Autism","enrollment":190},{"nctId":"NCT05840731","phase":"PHASE4","title":"Role of Ashwagandha Extract (Capsule KSM-66 300 mg) in Improving Sexual Health in Healthy Men","status":"UNKNOWN","sponsor":"SF Research Institute, Inc.","startDate":"2023-08-07","conditions":"Sexual Health","enrollment":45},{"nctId":"NCT04557215","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Rifaximin With NAC in IBS-D","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-11-13","conditions":"Irritable Bowel Syndrome With Diarrhea","enrollment":45},{"nctId":"NCT02081404","phase":"NA","title":"Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study","status":"COMPLETED","sponsor":"Midwest Biomedical Research Foundation","startDate":"2009-03-01","conditions":"Non-erosive Reflux Disease","enrollment":98},{"nctId":"NCT04602936","phase":"PHASE4","title":"Solriamfetol in Binge Eating Disorder","status":"UNKNOWN","sponsor":"Lindner Center of HOPE","startDate":"2021-06-15","conditions":"Binge Eating Disorder","enrollment":64},{"nctId":"NCT04504123","phase":"PHASE2","title":"MMP-9 Inhibition for Recalcitrant Wet AMD","status":"UNKNOWN","sponsor":"University of Iowa","startDate":"2020-11-04","conditions":"Exudative Macular Degeneration, Wet Age-related Macular Degeneration","enrollment":50},{"nctId":"NCT02865460","phase":"PHASE3","title":"Coenzyme Q10 Phase III Trial in Gulf War Illness","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2017-07-24","conditions":"Gulf War Illness, Chronic Fatigue, Ubiquinol","enrollment":100},{"nctId":"NCT03836001","phase":"PHASE2","title":"A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-04-18","conditions":"Epidermolysis Bullosa","enrollment":28},{"nctId":"NCT01613495","phase":"NA","title":"Ghrelin Suppression by Octreotide in Prader-Willi","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2005-08","conditions":"Prader Willis Syndrome","enrollment":2},{"nctId":"NCT01988584","phase":"PHASE2","title":"Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP).","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-11","conditions":"Cerebral Palsy","enrollment":20},{"nctId":"NCT03924323","phase":"PHASE4","title":"A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-05-30","conditions":"Anxiety Disorders,Generalized Anxiety Disorder","enrollment":273},{"nctId":"NCT05231603","phase":"PHASE3","title":"Ivermectin for Post Exposure Prophylaxis of Covid-19","status":"TERMINATED","sponsor":"Clinical Research Centre, Malaysia","startDate":"2022-02-16","conditions":"COVID-19","enrollment":50},{"nctId":"NCT04693286","phase":"PHASE2","title":"Clinical Trial of Novel OPV2 Vaccine","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2020-09-21","conditions":"Poliomyelitis","enrollment":330},{"nctId":"NCT05350124","phase":"PHASE3","title":"The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis","status":"UNKNOWN","sponsor":"King Abdulaziz University","startDate":"2022-11","conditions":"Restless Legs Syndrome, End Stage Renal Disease","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":51,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Inactive Substance","genericName":"Inactive Substance","companyName":"VA Office of Research and Development","companyId":"va-office-of-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}